EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1

Rui Sun iD, Siyu Lin iD, Luca Simonelli iD, Benedikt Strunz iD, Anish Behere iD, Mattia Pedotti iD, Tian Xu iD, Fanglei Zuo iD, Likun Du iD, Hui Wan iD, Sara Lestani iD, Leire de Campos-Mata iD und 17 weitere

Journal of Experimental Medicine · 02.11.2026 · 223 (12)

DOI: 10.1084/jem.20260268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 03.11.2026. Verfasst von Rui Sun und 28 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Polyendocrinopathies, Autoimmune, Autoantibodies, Interferon Type I, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Knut and Alice Wallenberg Foundation, Wallenberg Scholar, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoantibodies against type I IFNs can severely compromise antiviral defense, yet the mechanisms underlying their development remain elusive. Using high-throughput autoantigen profiling, we observed that a subgroup of severe COVID-19 patients exhibited strong binding to multiple type I IFNs. Integrated single-cell RNA and B cell receptor (BCR) sequencing with functional analysis identified B cell subsets/states enriched for IFN-α2–binding and –neutralizing antibodies in COVID-19. These findings were compared with those from patients with autoimmune polyendocrine syndrome type I, a rare genetic disease characterized by defective immune tolerance and persistent type I IFN autoimmunity. Competition surface plasmon resonance and AlphaFold 3 structural modeling identified three major functional epitope groups and seven predicted structural subclasses among neutralizing antibodies. Our results indicate that IFN-α2 autoreactivity is present in both naive and antigen-experienced B cell compartments, whereas functional IFN-neutralizing antibodies are predominantly associated with memory and atypical B cells, consistent with defective tolerance and affinity maturation-mediated selection of autoreactive B cell clones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyendocrinopathies, AutoimmuneAutoantibodiesInterferon Type ICOVID-19HumansSARS-CoV-2Antibodies, NeutralizingB-LymphocytesReceptors, Antigen, B-CellAutoantigensInterferon-alpha

Substanzen

AutoantibodiesInterferon Type IAntibodies, NeutralizingReceptors, Antigen, B-CellAutoantigensInterferon-alpha

Autor:innen und Institutionen

  • Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University , Beijing, China.
  • Institute for Research in Biomedicine, Università Della Svizzera Italiana , Bellinzona, Switzerland.
  • Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Rui Sun, Siyu Lin, Luca Simonelli, Benedikt Strunz, Anish Behere, Mattia Pedotti, Tian Xu, Fanglei Zuo, Likun Du, Hui Wan, Sara Lestani, Leire de Campos-Mata, Stelios Vlachiotis, Dorottya Kalmár, Kristoffer Strålin, Soo Aleman, Hans-Gustaf Ljunggren, Antonio Piralla, Fausto Baldanti, Olle Kämpe, Sophie Bensing, Lennart Hammarström, Nils Landegren, Zexian Zeng, Niklas K Björkström, Luca Varani, Harold Marcotte, Qiang Pan-Hammarström

Förderung

  • Knut and Alice Wallenberg Foundation
  • Wallenberg Scholar
  • Swedish Research Council
  • Horizon 2020 Research and Innovation Program
  • Nordstjernan
  • Swiss National Science Foundation
  • Karolinska Institutet

Zitieren

APA

Sun, R., Lin, S., Simonelli, L., Strunz, B., Behere, A., Pedotti, M., Xu, T., Zuo, F., Du, L., Wan, H., Lestani, S., de Campos-Mata, L., Vlachiotis, S., Kalmár, D., Karolinska KI/K COVID-19 Study Group, Strålin, K., Aleman, S., Ljunggren, H. G., Piralla, A., …, & Pan-Hammarström, Q. (2026). Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1. Journal of Experimental Medicine, 223(12). https://doi.org/10.1084/jem.20260268

Vancouver

Sun R, Lin S, Simonelli L, Strunz B, Behere A, Pedotti M, et al. Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1. Journal of Experimental Medicine. 2026;223(12). doi:10.1084/jem.20260268

BibTeX
@article{Sun2026,
  author = {Sun, Rui and Lin, Siyu and Simonelli, Luca and Strunz, Benedikt and Behere, Anish and Pedotti, Mattia and Xu, Tian and Zuo, Fanglei and Du, Likun and Wan, Hui and Lestani, Sara and de Campos-Mata, Leire and Vlachiotis, Stelios and Kalmár, Dorottya and Karolinska KI/K COVID-19 Study Group, Karolinska KI/K COVID-19 Study Group and Strålin, Kristoffer and Aleman, Soo and Ljunggren, Hans-Gustaf and Piralla, Antonio and Baldanti, Fausto and Kämpe, Olle and Bensing, Sophie and Hammarström, Lennart and Landegren, Nils and Zeng, Zexian and Björkström, Niklas K and Varani, Luca and Marcotte, Harold and Pan-Hammarström, Qiang},
  title = {Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {12},
  doi = {10.1084/jem.20260268}
}
Kostenlos starten →